Training to recognise the early signs of recurrence in schizophrenia
Referencias
Additional references
Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313:1200.
Amador XF, Flaum M, Friedman JH, Gorman JM, Kasapis C, Yale SA. Suicidal behaviour in schizophrenia and its relationship to awareness of illness. Americal Journal of Psychiatry 1996;153(9):1185‐8.
American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry1997; Vol. 154(4):1.
Bechdolf A, Halve S, Schulze‐Lutter F, Klosterkotter J. Self‐experienced vulnerability, prodromic symptoms and coping strategies before schizophrenic and affective episodes. Fortschr Neurol Psychiatr 1998;66:378‐86.
Birchwood M, Smith J, MacMillan F, Hogg B, Prasad R, Harvey C, Bering S. Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers, a preliminary investigation. Psychological Medicine 1989;19:649‐56.
Birchwood M, McGovern D, Spencer E. Management of first episode psychosis. Advances in Psychiatric Treatment 2001;7:133‐40.
Bland JM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600.
Bustillo J, Buchanan RW, Carpenter WT. Prodromal symptoms versus early warning signs and clinical action in schizophrenia. Schizophrenia Bulletin 1995;21:553‐59.
Carpenter WT, Buchanan RW, Kirkpatrick B, Breier AF. Diazepam treatment of early signs of exacerbation in schizophrenia. American Journal of Psychiatry 1999;156:299‐303.
Clarke M, Oxman AD. Cochrane Reviews Handbook 4.2.0. The Cochrane Library, 2003, Issue Issue 2.
Divine GW, Brown JT, Frazier LM. The unit of analysis error in studies about physicians' patient care behaviour. Journal of General Internal Medicine 1992;7(6):623‐9.
Dixon M, King S, Steiger H. The contribution of depression and denial towards understanding the unawareness of symptoms in schizophrenic outpatients. British Journal of Medical Psychology 1998;71(1):85‐97.
Donner A, Klar N. Issues in the meta‐analysis of cluster randomized trials. Statistics in Medicine 2002;21:2971‐80.
Gaebel W, Janner M, Frommann N, Pietzcker A, Kopcke W, Linden M, Muller P, Muller‐Spahn F, Tegeler J. First vs multiple episode schizophrenia: two year outcome of intermittent and maintenance medication strategies. Schizophrenia Research 2002;53:145‐59.
Gaebel W, Frick U, Kopcke W, Linden M, Muller P, Muller‐Spahn F, Pietzcker A, Tageler J. Early neuroleptic intervention in schizophrenia: are prodromal symptoms valid predictors of relapse?. British Journal of Psychiatry 1993;Suppl 21:8‐12.
Gulliford MC. Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876‐83.
Gumley A, O'Grady M, McNay L, Reilly J, Power K, Norrie J. Early intervention for relapse in schizophrenia: results of a 12 month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine 2003;33:419‐31.
Haddock G, Tarrier N, Spaulding W. Individual cognitive behavioural therapy in the treatment of hallucinations and delusions. Clinical Psychology Review 1998;18:821‐38.
Herz MI, Melville C. Relapse in schizophrenia. American Journal of Psychiatry 1980;137:801‐5.
Herz MI, Lamberti JS. Prodromal symptoms and relapse prevention in schizophrenia. Schizophrenia Bulletin 1995;21:541‐51.
Herz MI, Lamberti JS, Mintz J, Scott R, O'Dell SP, McCartan L, Nix G. A program for relapse prevention in schizophrenia: a controlled study. Archives of General Psychiatry 2000;57:277‐83.
Jolley AG, Hirsch SR, McRink A, Manchanda R. Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenia out‐patients: clinical outcome at one year. BMJ 1989;298:985‐90.
Jolley AG, Hirsch SR, Morrison E, McRink A, Wilson L. Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenia outpatients: clinical and social outcome at two years. BMJ 1990;301:837‐42.
Lam D, Wong G. Prodromes,coping strategies,insight and social functioning in bipolar affective disorders. Psychological Medicine 1997;27:1091‐1100.
Marder SR, Mintz J, Van Putten T, Lebell M, Wirshing WC, Johnston‐Cronk K. Early prediction of relapse in schizophrenia: an application of receiver operating characteristic (ROC) methods. Psychopharmacology Bulletin 1991;27:79‐82.
Marder SR, Wirshing WC, Van Putten T, Mintz J, McKenzie J, Johnston‐Cronk K, Lebell M, Lieberman RP. Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophrenia. Archives of General Psychiatry 1994;51:280‐87.
Marshall M, Lockwood A, Adams C, Bradley C, Joy C, Fenton M. Unpublished rating scales ‐ a major source of bias in randomised controlled trials of treatments for schizophrenia?. British Journal of Psychiatry 2000;176:249‐52.
Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area‐wide and organistation‐based intervention in health and health care: a systematic review. Health Technology Assessment 1999;3(5):1‐75.
